George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Misread on slater they're new
Offloading positoins, until Slater and Merchant f'eck uff this sp will drift between 2 and 3p
The problem with Haleon is that it's not GSK in name now.
If the RNS was that GSK has were distributing it, the share would have gone through the roof.
I'm pleased about this though as it's kept the SP low for me to get in, and the real value in Haleon is the sales they willa chieve. So it just means we have to wait for the £££££'s in updates to push the re rate instead..
But holding up well.
Was just in Tesco Pharmacy, both Viagra and Cialis had on front counter POS advertising their product, Eroxxon was just on the shelf.
Wonder if that's a pre emptive attack knowing it's there now as an alternative, or just fighting each other. Either way nice to see it in there on the shelf pride of place at front.
Talk about an anti-climax, was about to blow my load and the share price went all floppy right at the money shot
NO HARM DONE!
If you have erectile dysfunction you would try anything once as there's little in terms of official options.
Reviews are irrelevant, and if it works you will keep buying.
HAHA I recommend a photo of the tube to show you've bought it, and then maybe a wet carrot?
Looking at the published trades I can only assume there's a very large sell being worked at about £3.50.
Perhaps somebody doesn't want to wait for the next update, has given it lots of time and decided they want rid. That or a new shorter.
Looking good, deffo an II buyer in the background, expect a % update over the next 2 weeks.
50p by Friday
This share is a joke, shorters puppet.
And anybody who thinks this isn't Mike Ashley's fault is wrong, it's the bloody optoins causing this sh@te.
If they have any common sense they will employ an amazon specialist, or amazon agency.
I have a lot of knowledge in this field having worked with them, and they could easily rectify this.
The art is encouraging the good reviews and the right ones. Remember we can all buy a ticket.
So if you want to buy some, have a go and review it. IF YOU DO:
Wrrite a large review, lots of text, and include photos. These reviews rank better.
There's also a huge market for this stiffy juice in the porn and sex shop sectors.
License it out to ann summers or alike and repackage as Rampant Boner Gel, the old buggers will be using a tube a night w@nking' and sniffing used undies.
100% and the latest update was unexpected, how many more to come.
US Launch will send this ballistic, it will be the biggest stiffy on aim!
Where the II buying is out weighing the seller.
Over the past few weeks when volume's been this low, the SP has been pulled down, but not today.
For me NHS is less about £££ and more about exposure, it doesn't matter where they buy it. It's about the more mouths talking about it especially doctors.
That said some people can't afford, so there will be added £££ in people getting free healthcare..
In the background, can't see anybody stupid enough to be shorting this currently.
That said there's s tilla real lack of interest in this CURRENTLY.
Thankfully we're duel listed, and when EROXON goes on sale in the US I suspect for the ahre to gain more traction over there. And that US interest should help us keep some sustained rises here.
Not really fussed if pumpers get on board, as if there is a DS then from my point of view any volume is good volume to clear them off.
Will tend to go with the alternative that has least risk initially, before going to ones with more side effects.
So I hazard, Eroxon will be suggested as an initial choice pre tablets.
As for people going to pharmacies, A LOT of people tend to trust what doctors say more, often the same people that buy a brand over an own brand because they have a lack of trust.
Would not be surprised if this opens up a whole raft of new users.
Not forgetting many will get for free on NHS, and even then that a prescription will be cheaper than buying OTC.
They have engaged a comms agency now which is a good move, they've not been on board for long but look at where we are now, and there's lots of press about.
Give them a chance and I'm sure they'll get it right, they can't just pump the market with any old cheddar.
And sometimes it's better to rle a few bits into one, than say every thing individually.
Personally I see no need for RNS' now, the SP is chundering along nicely.
Much reflective on an insti stakebuilding, gonna be a hell of a ride here over next few months.
One up the FUM no harm done